{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:00:12Z","timestamp":1792393212810,"version":"4.4.0"},"publisher-location":"Basel","reference-count":200,"publisher":"Birkh\u00e4user Basel","isbn-type":[{"value":"9783764383374","type":"print"},{"value":"9783764383381","type":"electronic"}],"license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-3-7643-8338-1_15","type":"book-chapter","created":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T12:02:09Z","timestamp":1267444929000},"page":"519-541","source":"Crossref","is-referenced-by-count":2,"title":["Drugs of abuse: management of intoxication and antidotes"],"prefix":"10.1007","author":[{"given":"Ivan D.","family":"Montoya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"15_CR1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/pds.1626","volume":"17","author":"L.J. Paulozzi","year":"2008","unstructured":"Paulozzi LJ, Xi Y (2008) Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmaco epidemiol Drug Saf 17: 997\u20131005","journal-title":"Pharmaco epidemiol Drug Saf"},{"key":"15_CR2","first-page":"93","volume":"56","author":"CDC","year":"2007","unstructured":"CDC (2007) Unintentional poisoning deaths \u2014 United States, 1999\u20132004. MMWR Morb Mortal Wkly Rep 56: 93\u201396","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"15_CR3","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.2008.802","volume":"300","author":"A.J. Hall","year":"2008","unstructured":"Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, Crosby AE, Paulozzi LJ (2008) Patterns of abuse among unintentional pharmaceutical overdose fatalities. J Am Med Assoc 300: 2613\u20132620","journal-title":"J Am Med Assoc"},{"key":"15_CR4","first-page":"1245","volume":"55","author":"CDC","year":"2006","unstructured":"CDC (2006) Toxicology testing and results for suicide victims \u2014 13 states, 2004. MMWR Morb Mortal Wkly Rep 55: 1245\u20131248","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"15_CR5","unstructured":"Substance Abuse and Mental Health Services Administration, Office of Applied Studies (2008) Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits. DHHS Publication No. (SMA) 08-4339. Rockville, MD. DAWN Series D-30."},{"key":"15_CR6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pds.1276","volume":"15","author":"L.J. Paulozzi","year":"2006","unstructured":"Paulozzi LJ, Budnitz DS, Xi Y (2006) Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 15: 618\u2013627","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"15_CR7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/ip.2006.014357","volume":"13","author":"L.J. Paulozzi","year":"2007","unstructured":"Paulozzi LJ, Annest JL (2007) US data show sharply rising drug-induced death rates. Inj Prev 13: 130\u2013132.","journal-title":"Inj Prev"},{"key":"15_CR8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-81-4-534","volume":"81","author":"S.H. Snyder","year":"1974","unstructured":"Snyder SH, Pert CB, Pasternak GW (1974) The opiate receptor. Ann Intern Med 81: 534\u2013540","journal-title":"Ann Intern Med"},{"key":"15_CR9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archpsyc.1971.01750100069010","volume":"24","author":"C.R. Schuster","year":"1971","unstructured":"Schuster CR, Smith BB, Jaffe JH (1971) Drug abuse in heroin users. An experimental study of self-administration of methadone codeine, and pentazocine. Arch Gen Psychiatry 24: 359\u2013362","journal-title":"Arch Gen Psychiatry"},{"key":"15_CR10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0376-8716(86)90079-7","volume":"17","author":"D.R. Jasinski","year":"1986","unstructured":"Jasinski DR, Preston KL (1986) Comparison of intravenously administered methadone, morphine and heroin. Drug Alcohol Depend 17: 301\u2013310","journal-title":"Drug Alcohol Depend"},{"key":"15_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.1978.tb16761.x","volume":"311","author":"M.J. Kuhar","year":"1978","unstructured":"Kuhar MJ (1978) Opiate receptors: Some anatomical and physiological aspects. Ann NY Acad Sci 311: 35\u201348","journal-title":"Ann NY Acad Sci"},{"key":"15_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0736-4679(93)90007-T","volume":"11","author":"M.J. Utecht","year":"1993","unstructured":"Utecht MJ, Stone AF, McCarron MM (1993) Heroin body packers. J Emerg Med 11: 33\u201340","journal-title":"J Emerg Med"},{"key":"15_CR13","first-page":"546","volume":"50","author":"W. Cullen","year":"2000","unstructured":"Cullen W, Bury G., Langton D (2000) Experience of heroin overdose among drug users attending general practice. Br J Gen Pract 50: 546\u2013549","journal-title":"Br J Gen Pract"},{"key":"15_CR14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/09652149933108","volume":"94","author":"F. Tagliaro","year":"1999","unstructured":"Tagliaro F, De BZ (1999) Heroin overdose is often the truer description. Addiction 94: 973\u2013974","journal-title":"Addiction"},{"key":"15_CR15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.7326\/0003-4819-130-7-199904060-00019","volume":"130","author":"K.A. Sporer","year":"1999","unstructured":"Sporer KA (1999) Acute heroin overdose. Ann Intern Med 130: 584\u2013590","journal-title":"Ann Intern Med"},{"key":"15_CR16","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1046\/j.1360-0443.1996.91341310.x","volume":"91","author":"S. Darke","year":"1996","unstructured":"Darke S, Zador D (1996) Fatal heroin \u2018overdose\u2019: A review. Addiction 91: 1765\u20131772","journal-title":"Addiction"},{"key":"15_CR17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/0002-9343(71)90298-1","volume":"51","author":"J.L. Duberstein","year":"1971","unstructured":"Duberstein JL, Kaufman DM (1971) A clinical study of an epidemic of heroin intoxication and heroin-induced pulmonary edema. Am J Med 51: 704\u2013714","journal-title":"Am J Med"},{"key":"15_CR18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00000542-198307000-00018","volume":"59","author":"A.M. Safwat","year":"1983","unstructured":"Safwat AM, Daniel D (1983) Grand mal seizure after fentanyl administration. Anesthesiology 59: 78","journal-title":"Anesthesiology"},{"key":"15_CR19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/emj.19.3.264","volume":"19","author":"B. McCann","year":"2002","unstructured":"McCann B, Hunter R, McCann J (2002) Cocaine\/heroin induced rhabdomyolysis and ventricular fibrillation. Emerg Med J 19: 264\u2013265","journal-title":"Emerg Med J"},{"key":"15_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-4347(92)80527-W","volume":"580","author":"E.J. Cone","year":"1992","unstructured":"Cone EJ, Darwin WD (1992) Rapid assay of cocaine, opiates and metabolites by gas chromatography \u2014 mass spectrometry. J Chromatogr 580: 43\u201361","journal-title":"J Chromatogr"},{"key":"15_CR21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jat\/32.8.530","volume":"32","author":"E.J. Cone","year":"2008","unstructured":"Cone EJ, Caplan YH, Black DL, Robert T, Moser F (2008) Urine drug testing of chronic pain patients: Licit and illicit drug patterns. J Anal Toxicol 32: 530\u2013543","journal-title":"J Anal Toxicol"},{"key":"15_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jat\/18.1.22","volume":"18","author":"B.A. Goldberger","year":"1994","unstructured":"Goldberger BA, Cone EJ, Grant TM, Caplan YH, Levine BS, Smialek JE (1994) Disposition of heroin and its metabolites in heroin-related deaths. J Anal Toxicol 18: 22\u201328","journal-title":"J Anal Toxicol"},{"key":"15_CR23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jchromb.2006.02.002","volume":"833","author":"W. Yang","year":"2006","unstructured":"Yang W, Barnes AJ, Ripple MG, Fowler DR, Cone EJ, Moolchan ET, Chung H, Huestis MA (2006) Simultaneous quantification of methamphetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography\u2014mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 833: 210\u2013218","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"15_CR24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7748\/en2007.05.15.2.30.c4243","volume":"15","author":"P. Dixon","year":"2007","unstructured":"Dixon P (2007) Managing acute heroin overdose. Emerg Nurse 15: 30\u201335","journal-title":"Emerg Nurse"},{"key":"15_CR25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1046\/j.1360-0443.2002.00187.x","volume":"97","author":"J. Strang","year":"2002","unstructured":"Strang J (2002) Looking beyond death: Paying attention to other important consequences of heroin overdose. Addiction 97: 927\u2013928","journal-title":"Addiction"},{"key":"15_CR26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bmj.333.7569.614","volume":"333","author":"J. Strang","year":"2006","unstructured":"Strang J, Kelleher M, Best D, Mayet S, Manning V (2006) Emergency naloxone for heroin overdose. BMJ 333: 614\u2013615","journal-title":"BMJ"},{"key":"15_CR27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5694\/j.1326-5377.2002.tb04524.x","volume":"176","author":"J. Wasiak","year":"2002","unstructured":"Wasiak J, Clavisi O (2002) Is subcutaneous or intramuscular naloxone as effective as intravenous naloxone in the treatment of life-threatening heroin overdose? Med J Aust 176: 495","journal-title":"Med J Aust"},{"key":"15_CR28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0196-0644(87)80690-X","volume":"16","author":"R.F. Maio","year":"1987","unstructured":"Maio RF, Gaukel B, Freeman B (1987) Intralingual naloxone injection for narcotic-induced respiratory depression. Ann Emerg Med 16: 572\u2013573.","journal-title":"Ann Emerg Med"},{"key":"15_CR29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1553-2712.1998.tb02707.x","volume":"5","author":"K. Wanger","year":"1998","unstructured":"Wanger K, Brough L, Macmillan I, Goulding J, MacPhail I, Christenson JM (1998) Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose. Acad Emerg Med 5: 293\u2013299","journal-title":"Acad Emerg Med"},{"key":"15_CR30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1749-6632.1978.tb16779.x","volume":"311","author":"C.P. O\u2019Brien","year":"1978","unstructured":"O\u2019Brien CP, Greenstein R, Ternes J, Woody GE (1978) Clinical pharmacology of narcotic antagonists. Ann NY Acad Sci 311: 232\u2013240","journal-title":"Ann NY Acad Sci"},{"key":"15_CR31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/clpt.1989.10","volume":"45","author":"T.J. Gal","year":"1989","unstructured":"Gal TJ (1989) Naloxone reversal of buprenorphine-induced respiratory depression. Clin Pharmacol Ther 45: 66\u201371","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9378(85)90266-2","volume":"151","author":"J.G. Umans","year":"1985","unstructured":"Umans JG, Szeto HH (1985) Precipitated opiate abstinence in utero. Am J Obstet Gynecol 151: 441\u2013444","journal-title":"Am J Obstet Gynecol"},{"key":"15_CR33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9378(75)90613-4","volume":"122","author":"F.P. Zuspan","year":"1975","unstructured":"Zuspan FP, Gumpel JA, Mejia-Zelaya A, Madden J, Davis R (1975) Fetal stress from methadone withdrawal. Am J Obstet Gynecol 122: 43\u201346","journal-title":"Am J Obstet Gynecol"},{"key":"15_CR34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/FTD.0b013e3181816214","volume":"30","author":"J. Dowling","year":"2008","unstructured":"Dowling J, Isbister GK, Kirkpatrick CM, Naidoo D, Graudins A (2008) Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers. Ther Drug Monit 30: 490\u2013496","journal-title":"Ther Drug Monit"},{"key":"15_CR35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archinte.1968.00300070026005","volume":"122","author":"A.D. Steinberg","year":"1968","unstructured":"Steinberg AD, Karliner JS (1968) The clinical spectrum of heroin pulmonary edema. Arch Intern Med 122: 122\u2013127","journal-title":"Arch Intern Med"},{"key":"15_CR36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2105\/AJPH.2008.136937","volume":"99","author":"D. Kim","year":"2009","unstructured":"Kim D, Irwin KS, Khoshnood K (2009) Expanded access to naloxone: Options for critical response to the epidemic of opioid overdose mortality. Am J Public Health 99: 402\u2013407","journal-title":"Am J Public Health"},{"key":"15_CR37","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0196-0644(05)81276-4","volume":"22","author":"M. Brzozowski","year":"1993","unstructured":"Brzozowski M, Shih RD, Bania TC, Hoffman RS (1993) Discharging heroin overdose patients after observation. Ann Emerg Med 22: 1638\u20131639","journal-title":"Ann Emerg Med"},{"key":"15_CR38","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1553-2712.2000.tb01260.x","volume":"7","author":"J. Christenson","year":"2000","unstructured":"Christenson J, Etherington J, Grafstein E, Innes G, Pennington S, Wanger K, Fernandes C, Spinelli JJ, Gao M (2000) Early discharge of patients with presumed opioid overdose: Development of a clinical prediction rule. Acad Emerg Med 7: 1110\u20131118","journal-title":"Acad Emerg Med"},{"key":"15_CR39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1017\/S1481803500004863","volume":"2","author":"J. Etherington","year":"2000","unstructured":"Etherington J, Christenson J, Innes G, Grafstein E, Pennington S, Spinelli JJ, Gao M, Lahiffe B, Wanger K, Fernandes C (2000) Is early discharge safe after naloxone reversal of presumed opioid overdose? Can J Emerg Med 2: 156\u2013162","journal-title":"Can J Emerg Med"},{"key":"15_CR40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1470-8744.1999.tb00904.x","volume":"30","author":"A. Akbarzadeh","year":"1999","unstructured":"Akbarzadeh A, Mehraby M, Zarbakhsh M, Farzaneh H (1999) Design and synthesis of a morphine-6-succinyl-bovine serum albumin hapten for vaccine development. Biotechnol Appl Biochem 30: 139\u2013146","journal-title":"Biotechnol Appl Biochem"},{"key":"15_CR41","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","volume":"24","author":"B. Anton","year":"2006","unstructured":"Anton B, Leff P (2006) A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents. Vaccine 24: 3232\u20133240","journal-title":"Vaccine"},{"key":"15_CR42","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","volume":"252","author":"K.F. Bonese","year":"1974","unstructured":"Bonese KF, Wainer BH, Fitch FW, Rothberg RM, Schuster CR (1974) Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature 252: 708\u2013710","journal-title":"Nature"},{"key":"15_CR43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0031-6997(25)06605-0","volume":"25","author":"S. Spector","year":"1973","unstructured":"Spector S, Berkowitz B, Flynn EJ, Peskar B (1973) Antibodies to morphine, barbiturates, and serotonin. Pharmacol Rev 25: 281\u2013291","journal-title":"Pharmacol Rev"},{"key":"15_CR44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4049\/jimmunol.110.3.667","volume":"110","author":"B.H. Wainer","year":"1973","unstructured":"Wainer BH, Fitch FW, Fried J, Rothberg RM (1973) A measurement of the specificities of antibodies to morphine-6-succinyl-BSA by competitive inhibition of 14C-morphine binding. J Immunol 110: 667\u2013673","journal-title":"J Immunol"},{"key":"15_CR45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/241537a0","volume":"241","author":"B.H. Wainer","year":"1973","unstructured":"Wainer BH, Fitch FW, Rothberg RM, Schuster CR (1973) In vitro morphine antagonism by antibodies. Nature 241: 537\u2013538","journal-title":"Nature"},{"key":"15_CR46","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3109\/10826087309033104","volume":"8","author":"G.R. Gay","year":"1973","unstructured":"Gay GR, Sheppard CW, Inaba DS, Newmeyer JA (1973) An old girl: flyin\u2019 low, dyin\u2019 slow, blinded by snow: Cocaine in perspective. Int J Addict 8: 1027\u20131042","journal-title":"Int J Addict"},{"key":"15_CR47","first-page":"92","volume":"50","author":"R.K. Siegel","year":"1984","unstructured":"Siegel RK (1984) Changing patterns of cocaine use: Longitudinal observations, consequences, and treatment. NIDA Res Monogr 50: 92\u2013110","journal-title":"NIDA Res Monogr"},{"key":"15_CR48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.1986.03370010042021","volume":"225","author":"R.K. Siegel","year":"1986","unstructured":"Siegel RK, ElSohly MA, Plowman T, Rury PM, Jones RT (1986) Cocaine in herbal tea. J Am Med Assoc 225: 40","journal-title":"J Am Med Assoc"},{"key":"15_CR49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00043764-199302000-00006","volume":"35","author":"A.E. Floren","year":"1993","unstructured":"Floren AE, Small JW (1993) Mate de coca equals cocaine. J Occup Med 35: 95\u201396","journal-title":"J Occup Med"},{"key":"15_CR50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0379-0738(95)01860-3","volume":"77","author":"A.J. Jenkins","year":"1996","unstructured":"Jenkins AJ, Llosa T, Montoya I, Cone EJ (1996) Identification and quantitation of alkaloids in coca tea. Forensic Sci Int 77: 179\u2013189","journal-title":"Forensic Sci Int"},{"key":"15_CR51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0379-0738(91)90171-E","volume":"49","author":"G.F. Jackson","year":"1991","unstructured":"Jackson GF, Saady JJ, Poklis A (1991) Urinary excretion of benzoylecgonine following ingestion of Health Inca Tea. Forensic Sci Int 49: 57\u201364","journal-title":"Forensic Sci Int"},{"key":"15_CR52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0379-0738(94)01638-L","volume":"71","author":"A.F. Rump","year":"1995","unstructured":"Rump AF, Theisohn M, Klaus W (1995) The pathophysiology of cocaine cardiotoxicity. Forensic Sci Int 71: 103\u2013115","journal-title":"Forensic Sci Int"},{"key":"15_CR53","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0378-8741(81)90063-5","volume":"3","author":"G. Barnett","year":"1981","unstructured":"Barnett G, Hawks R, Resnick R (1981) Cocaine pharmacokinetics in humans. J Ethnopharmacol 3: 353\u2013366","journal-title":"J Ethnopharmacol"},{"key":"15_CR54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","volume":"98","author":"F. Leri","year":"2003","unstructured":"Leri F, Bruneau J, Stewart J (2003) Understanding polydrug use: Review of heroin and cocaine co-use. Addiction 98: 7\u201322","journal-title":"Addiction"},{"key":"15_CR55","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.amjmed.2008.11.022","volume":"122","author":"M.B. Patel","year":"2009","unstructured":"Patel MB, Opreanu M, Shah AJ, Pandya K, Bhadula R, Abela GS, Thakur RK (2009) Cocaine and alcohol: A potential lethal duo. Am J Med 122: e5\u2013e6","journal-title":"Am J Med"},{"key":"15_CR56","first-page":"247","volume":"1","author":"C.L. Renfroe","year":"1985","unstructured":"Renfroe CL, Messinger TA (1985) Street drug analysis: An eleven year perspective on illicit drug alteration. Semin Adolesc Med 1: 247\u2013257","journal-title":"Semin Adolesc Med"},{"key":"15_CR57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0736-4679(99)00198-5","volume":"18","author":"R. June","year":"2000","unstructured":"June R, Aks SE, Keys N, Wahl M (2000) Medical outcome of cocaine bodystuffers. J Emerg Med 18: 221\u2013224","journal-title":"J Emerg Med"},{"key":"15_CR58","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jama.1983.03340110031027","volume":"250","author":"M.M. McCarron","year":"1983","unstructured":"McCarron MM, Wood JD (1983) The cocaine \u2018body packer\u2019 syndrome. Diagnosis and treatment. J Am Med Assoc 250: 1417\u20131420","journal-title":"J Am Med Assoc"},{"key":"15_CR59","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.93.4.557","volume":"93","author":"S.H. Mott","year":"1994","unstructured":"Mott SH, Packer RJ, Soldin SJ (1994) Neurologic manifestations of cocaine exposure in childhood. Pediatrics 93: 557\u2013560","journal-title":"Pediatrics"},{"key":"15_CR60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0196-0644(05)80883-2","volume":"21","author":"R.S. Hoffman","year":"1992","unstructured":"Hoffman RS, Henry GC, Howland MA, Weisman RS, Weil L, Goldfrank LR (1992) Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med 21: 247\u2013253","journal-title":"Ann Emerg Med"},{"key":"15_CR61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00000433-200009000-00012","volume":"21","author":"D.M. Havlik","year":"2000","unstructured":"Havlik DM, Nolte KB (2000) Fatal \u201ccrack\u201d cocaine ingestion in an infant. Am J Forensic Med Pathol 21: 245\u2013248","journal-title":"Am J Forensic Med Pathol"},{"key":"15_CR62","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0006-3223(88)90222-3","volume":"24","author":"M.A. Sherer","year":"1988","unstructured":"Sherer MA (1988) Intravenous cocaine: Psychiatric effects, biological mechanisms. Biol Psychiatry 24: 865\u2013885","journal-title":"Biol Psychiatry"},{"key":"15_CR63","first-page":"210","volume":"150","author":"J.E. Bauwens","year":"1989","unstructured":"Bauwens JE, Boggs JM, Hartwell PS (1989) Fatal hyperthermia associated with cocaine use. West J Med 150: 210\u2013212","journal-title":"West J Med"},{"key":"15_CR64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0196-0644(94)70165-2","volume":"24","author":"C.W. Callaway","year":"1994","unstructured":"Callaway CW, Clark RF (1994) Hyperthermia in psychostimulant overdose. Ann Emerg Med 24: 68\u201376","journal-title":"Ann Emerg Med"},{"key":"15_CR65","first-page":"119","volume":"13","author":"R.K. Siegel","year":"1977","unstructured":"Siegel RK (1977) Cocaine: Recreational use and intoxication. NIDA Res Monogr 13: 119\u2013136","journal-title":"NIDA Res Monogr"},{"key":"15_CR66","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0735-6757(90)90181-X","volume":"8","author":"J.H. Zeiter","year":"1990","unstructured":"Zeiter JH, McHenry JG, McDermott ML (1990) Unilateral pharmacologic mydriasis secondary to crack cocaine. Am J Emerg Med 8: 568\u2013569","journal-title":"Am J Emerg Med"},{"key":"15_CR67","first-page":"838","volume":"17","author":"R.B. Daggett","year":"1990","unstructured":"Daggett RB, Haghighi P, Terkeltaub RA (1990) Nasal cocaine abuse causing an aggressive midline intranasal and pharyngeal destructive process mimicking midline reticulosis and limited Wegener\u2019s granulomatosis. J Rheumatol 17: 838\u2013840","journal-title":"J Rheumatol"},{"key":"15_CR68","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1590\/S1516-44462006000300010","volume":"28","author":"M. Ribeiro","year":"2006","unstructured":"Ribeiro M, Dunn J, Sesso R, Dias AC, Laranjeira R (2006) Causes of death among crack cocaine users. Rev Bras Psiquiatr 28: 196\u2013202","journal-title":"Rev Bras Psiquiatr"},{"key":"15_CR69","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1053\/ajem.2000.9282","volume":"18","author":"K. Blaho","year":"2000","unstructured":"Blaho K, Logan B, Winbery S, Park L, Schwilke E (2000) Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED. Am J Emerg Med 18: 593\u2013598","journal-title":"Am J Emerg Med"},{"key":"15_CR70","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/0002-8703(92)90090-I","volume":"124","author":"A. Om","year":"1992","unstructured":"Om A, Ellahham S, Ornato JP (1992) Reversibility of cocaine-induced cardiomyopathy. Am Heart J 124: 1639\u20131641","journal-title":"Am Heart J"},{"key":"15_CR71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1378\/chest.106.2.594","volume":"106","author":"H.J. Willens","year":"1994","unstructured":"Willens HJ, Chakko SC, Kessler KM (1994) Cardiovascular manifestations of cocaine abuse. A case of recurrent dilated cardiomyopathy. Chest 106: 594\u2013600","journal-title":"Chest"},{"key":"15_CR72","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0021-9673(94)85226-X","volume":"674","author":"C. Lora-Tamayo","year":"1994","unstructured":"Lora-Tamayo C, Tena T, Rodriguez A (1994) Cocaine-related deaths. J Chromatogr A 674: 217\u2013224","journal-title":"J Chromatogr A"},{"key":"15_CR73","first-page":"153","volume":"13","author":"B.S. Finkle","year":"1977","unstructured":"Finkle BS, McCloskey KL (1977) The forensic toxicology of cocaine. NIDA Res Monogr 13: 153\u2013192","journal-title":"NIDA Res Monogr"},{"key":"15_CR74","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/bmj.306.6883.1002","volume":"306","author":"M.L. Malbrain","year":"1993","unstructured":"Malbrain ML, Wauters A, Demeyer I, Demedts P, Verbraeken H, Daelemans R, Neels H (1993) Drug smuggler\u2019s delirium. BMJ 306: 1002","journal-title":"BMJ"},{"key":"15_CR75","first-page":"1504","volume":"97","author":"C.U. Nnadi","year":"2005","unstructured":"Nnadi CU, Mimiko OA, McCurtis HL, Cadet JL (2005) Neuropsychiatric effects of cocaine use disorders. J Natl Med Assoc 97: 1504\u20131515","journal-title":"J Natl Med Assoc"},{"issue":"Suppl 2","key":"15_CR76","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1528-1157.2002.043s2028.x","volume":"43","author":"P.G. Zagnoni","year":"2002","unstructured":"Zagnoni PG, Albano C (2002) Psychostimulants and epilepsy. Epilepsia 43 Suppl 2: 28\u201331","journal-title":"Epilepsia"},{"key":"15_CR77","doi-asserted-by":"crossref","first-page":"L379","DOI":"10.1016\/0024-3205(94)00694-6","volume":"55","author":"C.M. Pudiak","year":"1994","unstructured":"Pudiak CM, Bozarth MA (1994) Cocaine fatalities increased by restraint stress. Life Sci 55: L379\u2013L382","journal-title":"Life Sci"},{"key":"15_CR78","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.40.3_Part_1.404","volume":"40","author":"A. Pascual-Leone","year":"1990","unstructured":"Pascual-Leone A, Dhuna A, Altafullah I, Anderson DC (1990) Cocaine-induced seizures. Neurology 40: 404\u2013407","journal-title":"Neurology"},{"key":"15_CR79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00952999009001592","volume":"16","author":"L.D. Kramer","year":"1990","unstructured":"Kramer LD, Locke GE, Ogunyemi A, Nelson L (1990) Cocaine-related seizures in adults. Am J Drug Alcohol Abuse 16: 307\u2013317","journal-title":"Am J Drug Alcohol Abuse"},{"key":"15_CR80","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0002-9343(87)90640-1","volume":"83","author":"D.H. Lowenstein","year":"1987","unstructured":"Lowenstein DH, Massa SM, Rowbotham MC, Collins SD, McKinney HE, Simon RP (1987) Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med 83: 841\u2013846","journal-title":"Am J Med"},{"key":"15_CR81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1212\/WNL.34.5.675","volume":"34","author":"J.A. Myers","year":"1984","unstructured":"Myers JA, Earnest MP (1984) Generalized seizures and cocaine abuse. Neurology 34: 675\u2013676","journal-title":"Neurology"},{"key":"15_CR82","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7326\/0003-4819-132-12-200006200-00035","volume":"132","author":"H. Peyriere","year":"2000","unstructured":"Peyriere H, Mauboussin JM (2000) Cocaine-induced acute cytologic hepatitis in HIV-infected patients with nonactive viral hepatitis. Ann Intern Med 132: 1010\u20131011","journal-title":"Ann Intern Med"},{"key":"15_CR83","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ndt\/14.2.434","volume":"14","author":"F.J. Van der Woude","year":"1999","unstructured":"Van der Woude FJ, Waldherr R (1999) Severe renal arterio-arteriolosclerosis after cocaine use. Nephrol Dial Transplant 14: 434\u2013435","journal-title":"Nephrol Dial Transplant"},{"key":"15_CR84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/15563658708992619","volume":"25","author":"K.S. Merigian","year":"1987","unstructured":"Merigian KS, Roberts JR (1987) Cocaine intoxication: Hyperpyrexia, rhabdomyolysis and acute renal failure. J Toxicol Clin Toxicol 25: 135\u2013148","journal-title":"J Toxicol Clin Toxicol"},{"key":"15_CR85","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00007611-198803000-00020","volume":"81","author":"P.I. Menashe","year":"1988","unstructured":"Menashe PI, Gottlieb JE (1988) Hyperthermia, rhabdomyolysis, and myoglobinuric renal failure after recreational use of cocaine. South Med J 81: 379\u2013381","journal-title":"South Med J"},{"key":"15_CR86","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000185869","volume":"54","author":"F. Ahijado","year":"1990","unstructured":"Ahijado F, Garcia de V, Luno J (1990) Acute renal failure and rhabdomyolysis following cocaine abuse. Nephron 54: 268","journal-title":"Nephron"},{"key":"15_CR87","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000186582","volume":"59","author":"R. Enriquez","year":"1991","unstructured":"Enriquez R, Palacios FO, Gonzalez CM, Amoros FA, Cabezuelo JB, Hernandez F (1991) Skin vasculitis, hypokalemia and acute renal failure in rhabdomyolysis associated with cocaine. Nephron 59: 336\u2013337","journal-title":"Nephron"},{"key":"15_CR88","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/0003-4819-109-4-335","volume":"109","author":"B.C. Herzlich","year":"1988","unstructured":"Herzlich BC, Arsura EL, Pagala M, Grob D (1988) Rhabdomyolysis related to cocaine abuse. Ann Intern Med 109: 335\u2013336","journal-title":"Ann Intern Med"},{"key":"15_CR89","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02035108","volume":"11","author":"R. Beerman","year":"1986","unstructured":"Beerman R, Nunez D Jr, Wetli CV (1986) Radiographic evaluation of the cocaine smuggler. Gastrointest Radiol 11: 351\u2013354","journal-title":"Gastrointest Radiol"},{"key":"15_CR90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/15563659809162576","volume":"36","author":"R.S. Hoffman","year":"1998","unstructured":"Hoffman RS, Thompson T, Henry GC, Hatsukami DK, Pentel PR (1998) Variation in human plasma cholinesterase activity during low-dose cocaine administration. J Toxicol Clin Toxicol 36: 3\u20139","journal-title":"J Toxicol Clin Toxicol"},{"key":"15_CR91","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/taap.1997.8188","volume":"145","author":"C.E. Mattes","year":"1997","unstructured":"Mattes CE, Lynch TJ, Singh A, Bradley RM, Kellaris PA, Brady RO, Dretchen KL (1997) Therapeutic use of butyrylcholinesterase for cocaine intoxication. Toxicol Appl Pharmacol 145: 372\u2013380","journal-title":"Toxicol Appl Pharmacol"},{"key":"15_CR92","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0002-8703(93)90122-P","volume":"125","author":"A. Om","year":"1993","unstructured":"Om A, Ellahham S, Ornato JP, Picone C, Theogaraj J, Corretjer GP, Vetrovec GW (1993) Medical complications of cocaine: Possible relationship to low plasma cholinesterase enzyme. Am Heart J 125: 1114\u20131117","journal-title":"Am Heart J"},{"key":"15_CR93","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-3476(94)70379-5","volume":"124","author":"E.M. Ostrea Jr","year":"1994","unstructured":"Ostrea EM Jr, Romero A, Knapp DK, Ostrea AR, Lucena JE, Utarnachitt RB (1994) Postmortem drug analysis of meconium in early-gestation human fetuses exposed to cocaine: Clinical implications. J Pediatr 124: 477\u2013479","journal-title":"J Pediatr"},{"key":"15_CR94","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jat\/14.6.353","volume":"14","author":"P. Jacob III","year":"1990","unstructured":"Jacob P III, Lewis ER, Elias-Baker BA, Jones RT (1990) A pyrolysis product, anhydroecgonine methyl ester (methylecgonidine), is in the urine of cocaine smokers. J Anal Toxicol 14: 353\u2013357","journal-title":"J Anal Toxicol"},{"key":"15_CR95","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/00325481.1992.11701173","volume":"91","author":"J.K. Lobl","year":"1992","unstructured":"Lobl JK, Carbone LD (1992) Emergency management of cocaine intoxication. Counteracting the effects of today\u2019s \u2018favorite drug\u2019. Postgrad Med 91: 161\u2013166","journal-title":"Postgrad Med"},{"key":"15_CR96","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/01.CCM.0000063258.68159.71","volume":"31","author":"C.M. Shanti","year":"2003","unstructured":"Shanti CM, Lucas CE (2003) Cocaine and the critical care challenge. Crit Care Med 31: 1851\u20131859","journal-title":"Crit Care Med"},{"key":"15_CR97","first-page":"1238","volume":"297","author":"J.D. Catravas","year":"1977","unstructured":"Catravas JD, Waters IW, Walz MA, Davis WM (1977) Antidotes for cocaine poisoinign. N Engl J Med 297: 1238","journal-title":"N Engl J Med"},{"key":"15_CR98","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198912073212301","volume":"321","author":"R.A. Lange","year":"1989","unstructured":"Lange RA, Cigarroa RG, Yancy CW Jr, Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD (1989) Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 321: 1557\u20131562","journal-title":"N Engl J Med"},{"key":"15_CR99","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-112-12-897","volume":"112","author":"R.A. Lange","year":"1990","unstructured":"Lange RA, Cigarroa RG, Flores ED, McBride W, Kim AS, Wells PJ, Bedotto JB, Danziger RS, Hillis LD (1990) Potentiation of cocaine-induced coronary vasoconstriction by \u03b2-adrenergic blockage. Ann Intern Med 112: 897\u2013903","journal-title":"Ann Intern Med"},{"key":"15_CR100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0033-0620(97)80023-0","volume":"40","author":"W.R. Pitts","year":"1997","unstructured":"Pitts WR, Lange RA, Cigarroa JE, Hillis LD (1997) Cocaine-induced myocardial ischemia and infarction: Pathophysiology, recognition, and management. Prog Cardiovasc Dis 40: 65\u201376","journal-title":"Prog Cardiovasc Dis"},{"key":"15_CR101","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/CIRCULATIONAHA.107.188950","volume":"117","author":"J. McCord","year":"2008","unstructured":"McCord J, Jneid H, Hollander JE, de Lemos JA, Cercek B, Hsue P, Gibler WB, Ohman EM, Drew B, Philippides G, Newby LK (2008) Management of cocaine-associated chest pain and myocardial infarction: A scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 117: 1897\u20131907","journal-title":"Circulation"},{"key":"15_CR102","first-page":"1295","volume":"12","author":"R.G. Williams","year":"1996","unstructured":"Williams RG, Kavanagh KM, Teo KK (1996) Pathophysiology and treatment of cocaine toxicity: Implications for the heart and cardiovascular system. Can J Cardiol 12: 1295\u20131301","journal-title":"Can J Cardiol"},{"key":"15_CR103","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0735-6757(90)90155-S","volume":"8","author":"R.S. Hoffman","year":"1990","unstructured":"Hoffman RS, Smilkstein MJ, Goldfrank LR (1990) Whole bowel irrigation and the cocaine body-packer: A new approach to a common problem. Am J Emerg Med 8: 523\u2013527","journal-title":"Am J Emerg Med"},{"key":"15_CR104","first-page":"164","volume":"32","author":"R.S. Hoffman","year":"1990","unstructured":"Hoffman RS, Chiang WK, Weisman RS, Goldfrank LR (1990) Prospective evaluation of \u201ccrackvial\u201d ingestions. Vet Hum Toxicol 32: 164\u2013167","journal-title":"Vet Hum Toxicol"},{"key":"15_CR105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","volume":"58","author":"B.A. Martell","year":"2005","unstructured":"Martell BA, Mitchell E, Poling J, Gonsai K, Kosten TR (2005) Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry 58: 158\u2013164","journal-title":"Biol Psychiatry"},{"key":"15_CR106","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0264-410X(01)00425-X","volume":"20","author":"T.R. Kosten","year":"2002","unstructured":"Kosten TR, Rosen M, Bond J, Settles M, Roberts JS, Shields J, Jack L, Fox B (2002) Human therapeutic cocaine vaccine: Safety and immunogenicity. Vaccine 20: 1196\u20131204","journal-title":"Vaccine"},{"key":"15_CR107","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm1096-1129","volume":"2","author":"B.S. Fox","year":"1996","unstructured":"Fox BS, Kantak KM, Edwards MA, Black KM, Bollinger BK, Botka AJ, French TL, Thompson TL, Schad VC, Greenstein JL, Gefter ML, Exley MA, Swain PA, Briner TJ (1996) Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med 2: 1129\u20131132","journal-title":"Nat Med"},{"key":"15_CR108","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-3565(24)38818-4","volume":"296","author":"L. Koetzner","year":"2001","unstructured":"Koetzner L, Deng S, Sumpter TL, Weisslitz M, Abner RT, Landry DW, Woods JH (2001) Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys. J Pharmacol Exp Ther 296: 789\u2013796","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR109","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.106.111781","volume":"320","author":"A.B. Norman","year":"2007","unstructured":"Norman AB, Tabet MR, Norman MK, Buesing WR, Pesce AJ, Ball WJ (2007) A chimeric human\/murine anticocaine monoclonal antibody inhibits the distribution of cocaine to the brain in mice. J Pharmacol Exp Ther 320: 145\u2013153","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/jm030351z","volume":"47","author":"S. Paula","year":"2004","unstructured":"Paula S, Tabet MR, Farr CD, Norman AB, Ball WJ Jr (2004) Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody. J Med Chem 47: 133\u2013142","journal-title":"J Med Chem"},{"key":"15_CR111","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1124\/jpet.108.146407","volume":"328","author":"A.B. Norman","year":"2009","unstructured":"Norman AB, Norman MK, Buessing WR, Tabet MR, Tsibulsky VL, Ball WJ (2009) The effect of a chimeric human\/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats. J Pharmacol Exp Ther 328: 873\u2013881","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR112","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/mol.108.049486","volume":"75","author":"D. Gao","year":"2009","unstructured":"Gao D, Narasimhan DL, Macdonald J, Brim R, Ko MC, Landry DW, Woods JH, Sunahara RK, Zhan CG (2009) Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol Pharmacol 75: 318\u2013323","journal-title":"Mol Pharmacol"},{"key":"15_CR113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cbi.2008.04.024","volume":"175","author":"Y. Gao","year":"2008","unstructured":"Gao Y, LaFleur D, Shah R, Zhao Q, Singh M, Brimijoin S (2008) An albumin-butyryl-cholinesterase for cocaine toxicity and addiction: Catalytic and pharmacokinetic properties. Chem Biol Interact 175: 83\u201387","journal-title":"Chem Biol Interact"},{"key":"15_CR114","doi-asserted-by":"crossref","unstructured":"Jutkiewicz EM, Baladi MG, Cooper ZD, Narashimhan D, Sunahara RK, Woods JH (2008) A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality. Ann Emerg Med, in press","DOI":"10.1016\/j.annemergmed.2008.09.023"},{"key":"15_CR115","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1073\/pnas.95.17.10176","volume":"95","author":"B. Mets","year":"1998","unstructured":"Mets B, Winger G, Cabrera C, Seo S, Jamdar S, Yang G, Zhao K, Briscoe RJ, Almonte R, Woods JH, Landry DW (1998) A catalytic antibody against cocaine prevents cocaine\u2019s reinforcing and toxic effects in rats. Proc Natl Acad Sci USA 95: 10176\u201310181","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR116","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1039\/B716268E","volume":"6","author":"F. Zheng","year":"2008","unstructured":"Zheng F, Zhan CG (2008) Structure-and-mechanism-based design and discovery of therapeutics for cocaine overdose and addiction. Org Biomol Chem 6: 836\u2013843","journal-title":"Org Biomol Chem"},{"key":"15_CR117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.992","volume":"24","author":"K.S. Patrick","year":"2009","unstructured":"Patrick KS, Straughn AB, Perkins JS, Gonzalez MA (2009) Evolution of stimulants to treat ADHD: Transdermal methylphenidate. Hum Psychopharmacol 24: 1\u201317","journal-title":"Hum Psychopharmacol"},{"key":"15_CR118","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00558282","volume":"6","author":"P.S. Sever","year":"1973","unstructured":"Sever PS, Caldwell J, Dring LG, Williams RT (1973) The metabolism of amphetamine in dependent subjects. Eur J Clin Pharmacol 6: 177\u2013180","journal-title":"Eur J Clin Pharmacol"},{"key":"15_CR119","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1556-4029.2007.00518.x","volume":"52","author":"K. Takekawa","year":"2007","unstructured":"Takekawa K, Ohmori T, Kido A, Oya M (2007) Methamphetamine body packer: Acute poisoning death due to massive leaking of methamphetamine. J Forensic Sci 52: 1219\u20131222","journal-title":"J Forensic Sci"},{"key":"15_CR120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jat\/23.1.67","volume":"23","author":"N.M. Molina","year":"1999","unstructured":"Molina NM, Jejurikar SG (1999) Toxicological findings in a fatal ingestion of methamphetamine. J Anal Toxicol 23: 67\u201368","journal-title":"J Anal Toxicol"},{"key":"15_CR121","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1520\/JFS16085J","volume":"43","author":"B.K. Logan","year":"1998","unstructured":"Logan BK, Fligner CL, Haddix T (1998) Cause and manner of death in fatalities involving methamphetamine. J Forensic Sci 43: 28\u201334","journal-title":"J Forensic Sci"},{"key":"15_CR122","first-page":"528","volume":"97","author":"K.C. Lan","year":"1998","unstructured":"Lan KC, Lin YF, Yu FC, Lin CS, Chu P (1998) Clinical manifestations and prognostic features of acute methamphetamine intoxication. J Formos Med Assoc 97: 528\u2013533","journal-title":"J Formos Med Assoc"},{"key":"15_CR123","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/15563659409000444","volume":"32","author":"P. Chan","year":"1994","unstructured":"Chan P, Chen JH, Lee MH, Deng JF (1994) Fatal and nonfatal methamphetamine intoxication in the intensive care unit. J Toxicol Clin Toxicol 32: 147\u2013155","journal-title":"J Toxicol Clin Toxicol"},{"key":"15_CR124","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1360-0443.2006.01496.x","volume":"101","author":"R. McKetin","year":"2006","unstructured":"McKetin R, McLaren J, Lubman DI, Hides L (2006) The prevalence of psychotic symptoms among methamphetamine users. Addiction 101: 1473\u20131478","journal-title":"Addiction"},{"key":"15_CR125","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/clinchem\/41.6.955","volume":"41","author":"A.L. Nixon","year":"1995","unstructured":"Nixon AL, Long WH, Puopolo PR, Flood JG (1995) Bupropion metabolites produce false-positive urine amphetamine results. Clin Chem 41: 955\u2013956","journal-title":"Clin Chem"},{"key":"15_CR126","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1523\/JNEUROSCI.17-07-02551.1997","volume":"17","author":"D.S. Segal","year":"1997","unstructured":"Segal DS, Kuczenski R (1997) An escalating dose \u201cbinge\u201d model of amphetamine psychosis: Behavioral and neurochemical characteristics. J Neurosci 17: 2551\u20132566","journal-title":"J Neurosci"},{"key":"15_CR127","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jat\/16.1.19","volume":"16","author":"E.M. Thurman","year":"1992","unstructured":"Thurman EM, Pedersen MJ, Stout RL, Martin T (1992) Distinguishing sympathomimetic amines from amphetamine and methamphetamine in urine by gas chromatogrphy\/mass spectrometry. J Anal Toxicol 16: 19\u201327","journal-title":"J Anal Toxicol"},{"key":"15_CR128","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1097\/01.CCM.0000100123.50896.F0","volume":"31","author":"J.L. Zimmerman","year":"2003","unstructured":"Zimmerman JL (2003) Poisonings and overdoses in the intensive care unit: General and specific management issues. Crit Care Med 31: 2794\u20132801","journal-title":"Crit Care Med"},{"key":"15_CR129","first-page":"198","volume":"170","author":"J.R. Richards","year":"1999","unstructured":"Richards JR, Bretz SW, Johnson EB, Turnipseed SD, Brofeldt BT, Derlet RW (1999) Methamphetamine abuse and emergency department utilization. West J Med 170: 198\u2013202","journal-title":"West J Med"},{"key":"15_CR130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0735-6757(99)90159-6","volume":"17","author":"J.R. Richards","year":"1999","unstructured":"Richards JR, Johnson EB, Stark RW, Derlet RW (1999) Methamphetamine abuse and rhabdomyolysis in the ED: A 5-year study. Am J Emerg Med 17: 681\u2013685","journal-title":"Am J Emerg Med"},{"key":"15_CR131","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(03)01313-X","volume":"461","author":"K.A. Byrnes-Blake","year":"2003","unstructured":"Byrnes-Blake KA, Laurenzana EM, Carroll FI, Abraham P, Gentry WB, Landes RD, Owens SM (2003) Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats. Eur J Pharmacol 461: 119\u2013128","journal-title":"Eur J Pharmacol"},{"key":"15_CR132","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.intimp.2006.01.008","volume":"6","author":"W.B. Gentry","year":"2006","unstructured":"Gentry WB, Laurenzana EM, Williams DK, West JR, Berg RJ, Terlea T, Owens SM (2006) Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats. Int Immunopharmacol 6: 968\u2013977","journal-title":"Int Immunopharmacol"},{"key":"15_CR133","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4161\/hv.5.4.7456","volume":"5","author":"W.B. Gentry","year":"2009","unstructured":"Gentry WB, R\u00fcedi-Bettschen D, Owens SM (2009) Development of active and passive human vaccines to treat methamphetamine addiction. Hum Vaccin 5: 206\u2013213","journal-title":"Hum Vaccin"},{"key":"15_CR134","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1124\/jpet.103.061762","volume":"309","author":"D.E. McMillan","year":"2004","unstructured":"McMillan DE, Hardwick WC, Li M, Gunnell MG, Carroll FI, Abraham P, Owens SM (2004) Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat. J Pharmacol Exp Ther 309: 1248\u20131255","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0892-0362(91)90090-J","volume":"13","author":"D.E. Hutchings","year":"1991","unstructured":"Hutchings DE, Brake SC, Banks AN, Nero TJ, Dick LS, Zmitrovich AC (1991) Prenatal \u03949-tetrahydrocannabinol in the rat: Effects on auditory startle in adulthood. Neurotoxicol Teratol 13: 413\u2013416.","journal-title":"Neurotoxicol Teratol"},{"key":"15_CR136","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0031-6997(25)06863-2","volume":"38","author":"R.K. Razdan","year":"1986","unstructured":"Razdan RK (1986) Structure-activity relationships in cannabinoids. Pharmacol Rev 38: 75\u2013149","journal-title":"Pharmacol Rev"},{"key":"15_CR137","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000136462","volume":"11","author":"L.E. Hollister","year":"1974","unstructured":"Hollister LE (1974) Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of \u03949-tetrahydrocannabinol. Pharmacology 11: 3\u201311","journal-title":"Pharmacology"},{"key":"15_CR138","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cpt1974154380","volume":"15","author":"L. Lemberger","year":"1974","unstructured":"Lemberger L, McMahon R, Archer R, Matsumoto K, Rowe H (1974) Pharmacologic effects and physiologic disposition of \u03946a, 10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man. Clin Pharmacol Ther 15: 380\u2013386","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR139","doi-asserted-by":"crossref","first-page":"201S","DOI":"10.1002\/j.1552-4604.1981.tb02596.x","volume":"21","author":"M. Perez-Reyes","year":"1981","unstructured":"Perez-Reyes M, Owens SM, Di GS (1981) The clinical pharmacology and dynamics of marihuana cigarette smoking. J Clin Pharmacol 21: 201S\u2013207S","journal-title":"J Clin Pharmacol"},{"key":"15_CR140","doi-asserted-by":"crossref","unstructured":"Robson P (2005) Human studies of cannabinoids and medicinal cannabis. Handb Exp Pharmacol 719\u2013756","DOI":"10.1007\/3-540-26573-2_25"},{"key":"15_CR141","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2165\/00003495-200060060-00005","volume":"60","author":"E.M. Williamson","year":"2000","unstructured":"Williamson EM, Evans FJ (2000) Cannabinoids in clinical practice. Drugs 60: 1303\u20131314","journal-title":"Drugs"},{"key":"15_CR142","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF00450585","volume":"65","author":"R. Mechoulam","year":"1978","unstructured":"Mechoulam R, Carlini EA (1978) Toward drugs derived from cannabis. Naturwissenschaften 65: 174\u2013179","journal-title":"Naturwissenschaften"},{"key":"15_CR143","first-page":"106","volume":"21","author":"P. Bech","year":"1974","unstructured":"Bech P, Rafaelsen L, Rafaelsen OJ (1974) Cannabis: A psychopharmacological review. Dan Med Bull 21: 106\u2013120","journal-title":"Dan Med Bull"},{"key":"15_CR144","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5694\/j.1326-5377.1973.tb128792.x","volume":"2","author":"R. Thomas","year":"1973","unstructured":"Thomas R, Chesher G (1973) The pharmacology of marihuana. Med J Aust 2: 229\u2013237","journal-title":"Med J Aust"},{"key":"15_CR145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5694\/j.1326-5377.1986.tb101083.x","volume":"145","author":"G.G. Nahas","year":"1986","unstructured":"Nahas GG (1986) Cannabis: Toxicological properties and epidemiological aspects. Med J Aust 145: 82\u201387","journal-title":"Med J Aust"},{"key":"15_CR146","first-page":"457","volume":"95","author":"E.K. Johansson","year":"1989","unstructured":"Johansson EK, Hollister LE, Halldin MM (1989) Urinary elimination half-life of \u03941-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. NIDA Res Monogr 95: 457\u2013458","journal-title":"NIDA Res Monogr"},{"key":"15_CR147","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2165\/00023210-200418130-00005","volume":"18","author":"F.M. Leweke","year":"2004","unstructured":"Leweke FM, Gerth CW, Klosterkotter J (2004) Cannabis-associated psychosis: Current status of research. CNS Drugs 18: 895\u2013910","journal-title":"CNS Drugs"},{"key":"15_CR148","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.178.2.116","volume":"178","author":"A. Johns","year":"2001","unstructured":"Johns A (2001) Psychiatric effects of cannabis. Br J Psychiatry 178: 116\u2013122","journal-title":"Br J Psychiatry"},{"key":"15_CR149","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/070674377401900107","volume":"19","author":"A.M. Marcus","year":"1974","unstructured":"Marcus AM, Klonoff H, Low M (1974) Psychiatric status of the marihuana user. Can Psychiatr Assoc J 19: 31\u201339","journal-title":"Can Psychiatr Assoc J"},{"key":"15_CR150","first-page":"676","volume":"32","author":"J.S. Hochman","year":"1971","unstructured":"Hochman JS, Brill NQ (1971) Marijuana intoxication: Pharmacological and psychological factors. Dis Nerv Syst 32: 676\u2013679","journal-title":"Dis Nerv Syst"},{"key":"15_CR151","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/archpsyc.1976.01770030081012","volume":"33","author":"V.R. Thacore","year":"1976","unstructured":"Thacore VR, Shukla SR (1976) Cannabis psychosis and paranoid schizophrenia. Arch Gen Psychiatry 33: 383\u2013386","journal-title":"Arch Gen Psychiatry"},{"key":"15_CR152","first-page":"575","volume":"34","author":"D.C. MacInnes","year":"1984","unstructured":"MacInnes DC, Milleer KM (1984) Fatal coronary artery thrombosis associated with cannabis smoking. J R Coll Gen Pract 34: 575\u2013576","journal-title":"J R Coll Gen Pract"},{"key":"15_CR153","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/15563658108990042","volume":"18","author":"N.D. Vaziri","year":"1981","unstructured":"Vaziri ND, Thomas R, Sterling M, Seiff K, Pahl MV, Davila J, Wilson A (1981) Toxicity with intravenous injection of crude marijuana extract. Clin Toxicol 18: 353\u2013366","journal-title":"Clin Toxicol"},{"key":"15_CR154","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jat\/22.1.61","volume":"22","author":"M. Nihira","year":"1998","unstructured":"Nihira M, Hayashida M, Ohno Y, Inuzuka S, Yokota H, Yamamoto Y (1998) Urinalysis of body packers in Japan. J Anal Toxicol 22: 61\u201365","journal-title":"J Anal Toxicol"},{"key":"15_CR155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00063110-199506000-00009","volume":"2","author":"J.J. Osterwalder","year":"1995","unstructured":"Osterwalder JJ (1995) Patients intoxicated with heroin or heroin mixtures: How long should they be monitored? Eur J Emerg Med 2: 97\u2013101","journal-title":"Eur J Emerg Med"},{"key":"15_CR156","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/syn.20155","volume":"57","author":"B. Voytek","year":"2005","unstructured":"Voytek B, Berman SM, Hassid BD, Simon SL, Mandelkern MA, Brody AL, Monterosso J, Ling W, London ED (2005) Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusers. Synapse 57: 113\u2013115","journal-title":"Synapse"},{"key":"15_CR157","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.1976.tb27928.x","volume":"281","author":"R. Forney","year":"1976","unstructured":"Forney R, Martz R, Lemberger L, Rodda B (1976) The combined effect of marihuana and dextroamphetamine. Ann NY Acad Sci 281: 162\u2013170","journal-title":"Ann NY Acad Sci"},{"key":"15_CR158","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1021\/ja00779a049","volume":"94","author":"M.E. Wall","year":"1972","unstructured":"Wall ME, Brine DR, Pitt CG, Perez-Reyes M (1972) Identification of \u03949-tetrahydrocannabinol and metabolites in man. J Am Chem Soc 94: 8579\u20138581","journal-title":"J Am Chem Soc"},{"key":"15_CR159","first-page":"209","volume":"35","author":"G.J. DiGregorio","year":"1987","unstructured":"DiGregorio GJ, Sterling GH (1987) Marijuana pharmacology and urine testing. Am Fam Physician 35: 209\u2013212","journal-title":"Am Fam Physician"},{"key":"15_CR160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/jat\/22.6.445","volume":"22","author":"M.A. Huestis","year":"1998","unstructured":"Huestis MA, Cone EJ (1998) Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol 22: 445\u2013454","journal-title":"J Anal Toxicol"},{"key":"15_CR161","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/clpt.1986.171","volume":"40","author":"E.J. Cone","year":"1986","unstructured":"Cone EJ, Johnson RE (1986) Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clin Pharmacol Ther 40: 247\u2013256","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR162","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/10550490500528613","volume":"15","author":"E.B. Stuyt","year":"2006","unstructured":"Stuyt EB, Sajbel TA, Allen MH (2006) Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders. Am J Addict 15: 166\u2013173","journal-title":"Am J Addict"},{"key":"15_CR163","first-page":"177","volume":"14","author":"M. Berk","year":"1999","unstructured":"Berk M, Brook S, Trandafir AI (1999) A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: A double-blind randomized controlled trial. Int Clin Psychopharmacol 14: 177\u2013180","journal-title":"Int Clin Psychopharmacol"},{"key":"15_CR164","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0733-8627(20)30258-3","volume":"8","author":"E.B. Baldridge","year":"1990","unstructured":"Baldridge EB, Bessen HA (1990) Phencyclidine. Emerg Med Clin North Am 8: 541\u2013550","journal-title":"Emerg Med Clin North Am"},{"key":"15_CR165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/15563657608988151","volume":"9","author":"R.S. Burns","year":"1976","unstructured":"Burns RS, Lerner SE (1976) Perspectives: Acute phencyclidine intoxication. Clin Toxicol 9: 477\u2013501","journal-title":"Clin Toxicol"},{"key":"15_CR166","first-page":"209","volume":"64","author":"M.M. McCarron","year":"1986","unstructured":"McCarron MM (1986) Phencyclidine intoxication. NIDA Res Monogr 64: 209\u2013217","journal-title":"NIDA Res Monogr"},{"key":"15_CR167","first-page":"2035","volume":"78","author":"J.P. Morgan","year":"1978","unstructured":"Morgan JP, Solomon JL (1978) Phencyclidine. Clinical pharmacology and toxicity. NY State J Med 78: 2035\u20132038","journal-title":"NY State J Med"},{"key":"15_CR168","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jat\/14.6.368","volume":"14","author":"W. Bronner","year":"1990","unstructured":"Bronner W, Nyman P, von Minden D (1990) Detectability of phencyclidine and 11-nor-\u03949-tetrahydrocannabinol-9-carboxylic acid in adulterated urine by radioimmunoassay and fluorescence polarization immunoassay. J Anal Toxicol 14: 368\u2013371","journal-title":"J Anal Toxicol"},{"key":"15_CR169","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/15563657809150017","volume":"12","author":"R.S. Burns","year":"1978","unstructured":"Burns RS, Lerner SE (1978) Causes of phencyclidine-related deaths. Clin Toxicol 12: 463\u2013481","journal-title":"Clin Toxicol"},{"key":"15_CR170","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0022-3565(25)38267-4","volume":"265","author":"S.M. Owens","year":"1993","unstructured":"Owens SM, Gunnell M, Laurenzana EM, Valentine JL (1993) Dose-and time-dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1. J Pharmacol Exp Ther 265: 1261\u20131266","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR171","first-page":"50","volume":"93","author":"L.B. Baskin","year":"1997","unstructured":"Baskin LB, Morgan DL (1997) Drugs detected in patients suspected of acute intoxication. Tex Med 93: 50\u201358","journal-title":"Tex Med"},{"key":"15_CR172","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/archneur.1982.00510170058019","volume":"39","author":"R.J. Fallis","year":"1982","unstructured":"Fallis RJ, Aniline O, Weiner LP, Pitts FN Jr (1982) Massive phencyclidine intoxication. Arch Neurol 39: 316","journal-title":"Arch Neurol"},{"key":"15_CR173","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0091-3057(86)90336-9","volume":"24","author":"D.J. McCann","year":"1986","unstructured":"McCann DJ, Winter JC (1986) Effects of phencyclidine, N-allyl-N-normetazocine (SKF-10,047), and verapamil on performance in a radial maze. Pharmacol Biochem Behav 24: 187\u2013191","journal-title":"Pharmacol Biochem Behav"},{"key":"15_CR174","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/15563658008989980","volume":"16","author":"R.T. Rappolt Sr","year":"1980","unstructured":"Rappolt RT Sr, Gay GR, Farris RD (1980) Phencyclidine (PCP) intoxication: Diagnosis in stages and algorithms of treatment. Clin Toxicol 16: 509\u2013529","journal-title":"Clin Toxicol"},{"key":"15_CR175","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1176\/ajp.138.5.674","volume":"138","author":"S. Walker","year":"1981","unstructured":"Walker S, Yesavage JA, Tinklenberg JR (1981) Acute phencyclidine (PCP) intoxication: Quantitative urine levels and clinical management. Am J Psychiatry 138: 674\u2013675","journal-title":"Am J Psychiatry"},{"key":"15_CR176","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archinte.1980.00330160128046","volume":"140","author":"C. H. Barton","year":"1980","unstructured":"Barton C H, Sterling ML, Vaziri ND (1980) Rhabdomyolysis and acute renal failure associated with phencyclidine intoxication. Arch Intern Med 140: 568\u2013569","journal-title":"Arch Intern Med"},{"key":"15_CR177","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.1982.03330050067036","volume":"248","author":"H.A. Bessen","year":"1982","unstructured":"Bessen HA (1982) Intracranial hemorrhage associated with phencyclidine abuse. J Am Med Assoc 248: 585\u2013586","journal-title":"J Am Med Assoc"},{"key":"15_CR178","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00004714-198812000-00003","volume":"8","author":"M. Brecher","year":"1988","unstructured":"Brecher M, Wang BW, Wong H, Morgan JP (1988) Phencyclidine and violence: Clinical and legal issues. J Clin Psychopharmacol 8: 397\u2013401","journal-title":"J Clin Psychopharmacol"},{"key":"15_CR179","first-page":"345","volume":"123","author":"R.S. Burns","year":"1975","unstructured":"Burns RS, Lerner SE, Corrado R, James SH, Schnoll SH (1975) Phencyclidine \u2014 States of acute intoxication and fatalities. West J Med 123: 345\u2013349","journal-title":"West J Med"},{"key":"15_CR180","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-88-2-210","volume":"88","author":"F.C. Cogen","year":"1978","unstructured":"Cogen FC, Rigg G, Simmons JL, Domino EF (1978) Phencyclidine-associated acute rhabdomyolysis. Ann Intern Med 88: 210\u2013212","journal-title":"Ann Intern Med"},{"key":"15_CR181","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/jama.1975.03240240040024","volume":"231","author":"J.W. Eastman","year":"1975","unstructured":"Eastman JW, Cohen SN (1975) Hypertensive crisis and death associated with phencyclidine poisoning. J Am Med Assoc 231: 1270\u20131271","journal-title":"J Am Med Assoc"},{"key":"15_CR182","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0196-0644(81)80118-7","volume":"10","author":"M.M. McCarron","year":"1981","unstructured":"McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA (1981) Acute phencyclidine intoxication: Clinical patterns, complications, and treatment. Ann Emerg Med 10: 290\u2013297","journal-title":"Ann Emerg Med"},{"key":"15_CR183","first-page":"535","volume":"7","author":"G.Y. Stein","year":"2005","unstructured":"Stein GY, Fradin Z, Ori Y, Singer P, Korobko Y, Zeidman A (2005) Phencyclidine-induced multiorgan failure. Isr Med Assoc J 7: 535\u2013537","journal-title":"Isr Med Assoc J"},{"key":"15_CR184","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/milmed\/138.9.590","volume":"138","author":"J.I. Stein","year":"1973","unstructured":"Stein JI (1973) Phencyclidine induced psychosis. The need to avoid unnecessary sensory influx. Mil Med 138: 590\u2013591","journal-title":"Mil Med"},{"key":"15_CR185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jat\/12.4.180","volume":"12","author":"M.A. ElSohly","year":"1988","unstructured":"ElSohly MA, Little TL Jr, Mitchell JM, Paul BD, Mell LD Jr, Irving J (1988) GC\/MS analysis of phencyclidine acid metabolite in human urine. J Anal Toxicol 12: 180\u2013182","journal-title":"J Anal Toxicol"},{"key":"15_CR186","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/jat\/14.3.192","volume":"14","author":"M.A. ElSohly","year":"1990","unstructured":"ElSohly MA, Stanford DF (1990) Cutoff of 25 ng\/mL for the EMIT d.a.u. phencyclidine assay. J Anal Toxicol 14: 192\u2013193","journal-title":"J Anal Toxicol"},{"key":"15_CR187","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jat\/8.5.197","volume":"8","author":"M.M. McCarron","year":"1984","unstructured":"McCarron MM, Walberg CB, Soares JR, Gross SJ, Baselt RC (1984) Detection of phencyclidine usage by radioimmunoassay of saliva. J Anal Toxicol 8: 197\u2013201","journal-title":"J Anal Toxicol"},{"key":"15_CR188","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/jat\/7.2.106","volume":"7","author":"C.B. Walberg","year":"1983","unstructured":"Walberg CB, McCarron MM, Schulze BN (1983) Quantitation of phencyclidine in serum by enzyme immunoassay: Results in 405 patients. J Anal Toxicol 7: 106\u2013110","journal-title":"J Anal Toxicol"},{"key":"15_CR189","first-page":"477","volume":"47","author":"D. Grover","year":"1986","unstructured":"Grover D, Yeragani VK, Keshavan MS (1986) Improvement of phencyclidine-associated psychosis with ECT. J Clin Psychiatry 47: 477\u2013478","journal-title":"J Clin Psychiatry"},{"key":"15_CR190","first-page":"184","volume":"44","author":"H.W. Lahmeyer","year":"1983","unstructured":"Lahmeyer HW, Stock PG (1983) Phencyclidine intoxication, physical restraint, and acute renal failure: Case report. J Clin Psychiatry 44: 184\u2013185","journal-title":"J Clin Psychiatry"},{"key":"15_CR191","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0361-1124(79)80040-4","volume":"8","author":"R.T. Rappolt","year":"1979","unstructured":"Rappolt RT, Gay GR, Farris RD (1979) Emergency management of acute phencyclidine intoxication. J Am Coll Emerg Physicians-JACEP 8: 68\u201376","journal-title":"J Am Coll Emerg Physicians-JACEP"},{"key":"15_CR192","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/jpet.302.1.119","volume":"302","author":"J.S. Hardin","year":"2002","unstructured":"Hardin JS, Wessinger WD, Wenger GR, Proksch JW, Laurenzana EM, Owens SM (2002) A single dose of monoclonal anti-phencyclidine IgG offers long-term reductions in phencyclidine behavioral effects in rats. J Pharmacol Exp Ther 302: 119\u2013126","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR193","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1124\/jpet.103.053140","volume":"306","author":"E.M. Laurenzana","year":"2003","unstructured":"Laurenzana EM, Gunnell MG, Gentry WB, Owens SM (2003) Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody. J Pharmacol Exp Ther 306: 1092\u20131098","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR194","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0090-9556(24)15342-1","volume":"28","author":"J.W. Proksch","year":"2000","unstructured":"Proksch JW, Gentry WB, Owens SM (2000) The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum. Drug Metab Dispos 28: 742\u2013747","journal-title":"Drug Metab Dispos"},{"key":"15_CR195","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0022-3565(25)38842-7","volume":"269","author":"J.L. Valentine","year":"1994","unstructured":"Valentine JL, Arnold LW, Owens SM (1994) Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats. J Pharmacol Exp Ther 269: 1079\u20131085","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR196","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0022-3565(25)20654-1","volume":"278","author":"J.L. Valentine","year":"1996","unstructured":"Valentine JL, Mayersohn M, Wessinger WD, Arnold LW, Owens SM (1996) Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats. J Pharmacol Exp Ther 278: 709\u2013716","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR197","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0022-3565(25)20655-3","volume":"278","author":"J.L. Valentine","year":"1996","unstructured":"Valentine JL, Owens SM (1996) Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats. J Pharmacol Exp Ther 278: 717\u2013724","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR198","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/dmd.105.005934","volume":"34","author":"G. Pitas","year":"2006","unstructured":"Pitas G, Laurenzana EM, Williams DK, Owens SM, Gentry WB (2006) Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted. Drug Metab Dispos 34: 906\u2013912","journal-title":"Drug Metab Dispos"},{"key":"15_CR199","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0022-3565(24)35360-1","volume":"292","author":"J.W. Proksch","year":"2000","unstructured":"Proksch JW, Gentry WB, Owens, SM (2000) Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats. J Pharmacol Exp Ther 292: 831\u2013837","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2007.09.020","volume":"8","author":"H.M. Lacy","year":"2008","unstructured":"Lacy HM, Gunnell MG, Laurenzana EM, Owens, SM (2008) Engineering and characterization of a mouse\/human chimeric anti-phencyclidine monoclonal antibody. Int Immunopharmacol 8: 1\u201311","journal-title":"Int Immunopharmacol"}],"container-title":["Experientia Supplementum","Molecular, Clinical and Environmental Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7643-8338-1_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T12:32:56Z","timestamp":1749126776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-7643-8338-1_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9783764383374","9783764383381"],"references-count":200,"URL":"https:\/\/doi.org\/10.1007\/978-3-7643-8338-1_15","relation":{},"ISSN":["1023-294X"],"issn-type":[{"value":"1023-294X","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}